Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Completed · Phase 4

Conditions studied: Opioid Dependence, Substance-Related Disorders

In brief

The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.

Key facts

Study ID

NCT00015340

Run by

National Institute on Drug Abuse (NIDA)

People needed

582

Starts

1999-08-01

Expected to finish

2001-09-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 59. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Completion of Cooperative Study 1008 A/B

You may not qualify if…

• Significant medical or psychiatric illness. Non-compliance with study procedures in the Cooperative Study 1008 A/B

Where it is running

• University of California — Los Angeles, California, United States
• VA Medical Center — Tampa, Florida, United States
• VA Medical Center — Hines, Illinois, United States
• New York VAMC — New York, New York, United States
• VA PUget Sound Helath Care System — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.